Bone Adhesive

  • Release Of Our Very First OssiVet® Order!

    , ,

    The PBC Biovet Operations Team has reached a significant milestone with the preparation and release of our very first OssiVet® order! OssiVet®, our innovative veterinary bioadhesive bone substitute, is designed to support advanced orthopedic care for companion animals, combining safety, efficacy, and ease of use. This landmark achievement is a testament to our team’s hard…

    Read More...

  • PBC Biomed OTA Symposium – Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration.

    , , , , ,

    We are delighted to announce that we will be continuing our ‘Strengthening the Bond’ education series at the Orthopaedic Trauma Association meeting in Montreal this week. Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration. Our global panel of surgeon advisors will discuss current hashtag#Biomaterials and their challenges, as well as plans for…

    Read More...

  • DTIF Project Consortium Progress Meeting

    , , , , , , ,

    It was fantastic to welcome the Enterprise Ireland #DTIF consortium team to our Shannon Headquarters at the start of September for a project progress meeting. Thank you to Nicholas Dunne and the DCU postgraduate team, the Dolmen Design & Innovation team, as well as Jackie FitzGerald of Enterprise Ireland for making the trip! #DTIF #disruptivetechnology…

    Read More...

  • Exciting New Hires for Biomimetic Innovations

    ,

    PBC Biomed would like to welcome our two newest members to the Biomimetic Innovations Ltd team – Quality Specialist Annmarie Donnellan (left) and Director of Operations Ann Marie Ryan (right). We are delighted to have you both on board – exciting times ahead for BMI and the development of OsStic® Technology! #newhire #operations #biomimeticinnovations #acceleratingmedicalinnovation

    Read More...

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

  • FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. 

    , , ,

    Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…

    Read More...

  • PBC Biomed to Lead Consortium in Development of Bone Adhesive

    ,

     PBC Biomed_Our Why.mp4 SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for…

    Read More...

  • DSM and PBC Partnership to develop regenerative bone adhesives

    ,

    DSM and PBC Biomed partner to develop regenerative bone adhesives for safer, more cost-effective surgical procedures. Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and PBC Biomed, a medical device design and development company, have signed an agreement to jointly design and develop novel materials for medical devices. Initially, the agreement…

    Read More...